Arch Venture Partners

1 trends tracked about this subject — the full history, oldest to newest below.

▲ Peaking Business

Sentivera emerges as a new immunology biotech via a $1.5 billion licensing agreement between China's Haisco and US-based venture capitalists.

5 sources 5 articles v 3 2h ago